BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19690339)

  • 21. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia.
    Messmer BT; Albesiano E; Efremov DG; Ghiotto F; Allen SL; Kolitz J; Foa R; Damle RN; Fais F; Messmer D; Rai KR; Ferrarini M; Chiorazzi N
    J Exp Med; 2004 Aug; 200(4):519-25. PubMed ID: 15314077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.
    Visco C; Maura F; Tuana G; Agnelli L; Lionetti M; Fabris S; Novella E; Giaretta I; Reda G; Barcellini W; Baldini L; Neri A; Rodeghiero F; Cortelezzi A
    Clin Cancer Res; 2012 Apr; 18(7):1870-8. PubMed ID: 22322667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.
    Darzentas N; Stamatopoulos K
    Hematol Oncol Clin North Am; 2013 Apr; 27(2):237-50. PubMed ID: 23561471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
    Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
    Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression.
    Pede V; Rombout A; Vermeire J; Naessens E; Mestdagh P; Robberecht N; Vanderstraeten H; Van Roy N; Vandesompele J; Speleman F; Philippé J; Verhasselt B
    PLoS One; 2013; 8(4):e60275. PubMed ID: 23560086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiotypic cross-reactivity of immunoglobulins expressed in Waldenström's macroglobulinemia, chronic lymphocytic leukemia, and mantle zone lymphocytes of secondary B-cell follicles.
    Axelrod O; Silverman GJ; Dev V; Kyle R; Carson DA; Kipps TJ
    Blood; 1991 Apr; 77(7):1484-90. PubMed ID: 1901234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.
    Chu CC; Catera R; Zhang L; Didier S; Agagnina BM; Damle RN; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chiorazzi N
    Blood; 2010 May; 115(19):3907-15. PubMed ID: 20110421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution.
    Kostareli E; Sutton LA; Hadzidimitriou A; Darzentas N; Kouvatsi A; Tsaftaris A; Anagnostopoulos A; Rosenquist R; Stamatopoulos K
    Leukemia; 2010 Jul; 24(7):1317-24. PubMed ID: 20463750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subjects with chronic lymphocytic leukaemia-like B-cell clones with stereotyped B-cell receptors frequently show MDS-associated phenotypes on myeloid cells.
    Rodríguez-Caballero A; Henriques A; Criado I; Langerak AW; Matarraz S; López A; Balanzategui A; González M; Nieto WG; Cortesão E; Paiva A; Almeida J; Orfao A
    Br J Haematol; 2015 Jan; 168(2):258-67. PubMed ID: 25252186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.
    Yan XJ; Albesiano E; Zanesi N; Yancopoulos S; Sawyer A; Romano E; Petlickovski A; Efremov DG; Croce CM; Chiorazzi N
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11713-8. PubMed ID: 16864779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.
    Tobin G; Thunberg U; Johnson A; Eriksson I; Söderberg O; Karlsson K; Merup M; Juliusson G; Vilpo J; Enblad G; Sundström C; Roos G; Rosenquist R
    Blood; 2003 Jun; 101(12):4952-7. PubMed ID: 12586612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
    Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
    Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin genes in chronic lymphocytic leukemia.
    Kipps TJ
    Blood Cells; 1993; 19(3):615-25; discussion 631-2. PubMed ID: 8018942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic Leukemia.
    Rovida A; Maccalli C; Scarfò L; Dellabona P; Stamatopoulos K; Ghia P
    Clin Cancer Res; 2021 Feb; 27(3):729-739. PubMed ID: 33051305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.
    Tschumper RC; Geyer SM; Campbell ME; Kay NE; Shanafelt TD; Zent CS; Nowakowski GS; Call TG; Dewald GW; Jelinek DF
    J Clin Invest; 2008 Jan; 118(1):306-15. PubMed ID: 18064298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.
    Mauerer K; Zahrieh D; Gorgun G; Li A; Zhou J; Ansén S; Rassenti LZ; Gribben JG
    Br J Haematol; 2005 May; 129(4):499-510. PubMed ID: 15877732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.
    Gounari M; Ntoufa S; Apollonio B; Papakonstantinou N; Ponzoni M; Chu CC; Rossi D; Gaidano G; Chiorazzi N; Stamatopoulos K; Ghia P
    Blood; 2015 Jun; 125(23):3580-7. PubMed ID: 25900981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.
    Widhopf GF; Goldberg CJ; Toy TL; Rassenti LZ; Wierda WG; Byrd JC; Keating MJ; Gribben JG; Rai KR; Kipps TJ
    Blood; 2008 Mar; 111(6):3137-44. PubMed ID: 17675554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.
    Ghiotto F; Fais F; Albesiano E; Sison C; Valetto A; Gaidano G; Reinhardt J; Kolitz JE; Rai K; Allen SL; Ferrarini M; Chiorazzi N
    Mol Med; 2006; 12(11-12):300-8. PubMed ID: 17380195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.